Journals / Selçuk Tıp Dergisi / 2021 / Cilt: 37 - Sayı: 4

18F-FDG PET/CT Findings in Esophageal Ca Staging: A Retrospective Analysis

Özofagus Ca Evrelemede 18F-FDG PET/BT Bulgularımız: Bir Retrospektif Analiz

Pages
345–350
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our study supports this.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to retrospectively analyze and present the findings of patients diagnosed with esophageal cancer and staged using 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) imaging.
📊
Key Findings & Data:Patients and Methods: Thirty-seven patients diagnosed with esophagus who were staged with 18F-FDG PET/CT in our hospital between February 2015 and February 2020 were included in this study.
💡
Conclusion & Impact:Our study supports this.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to retrospectively analyze and present the findings of patients diagnosed with esophageal cancer and staged using 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) imaging. Patients and Methods: Thirty-seven patients diagnosed with esophagus who were staged with 18F-FDG PET/CT in our hospital between February 2015 and February 2020 were included in this study. Patients' age, gender, localization of the primary tumor and 18F-FDG PET/CT maximum standardized uptake value (SUVmax), findings of metastases to mediastinal, abdominal and cervical lymph nodes, lung, liver, bone and other areas were retrospectively evaluated as. Results: The meanage of the patients was 66,97 ± 14,54 years. 20 patients (54%) were male, 17 patients (46%) were female. 10 patients (27%) had upper esophagus tumors, 23 patients (62%) had lower esophagus tumors, 4 patients had middle esophageal tumors (11%). The pathological diagnosis of 23 patients was sTuamous cell ca, 14 patients were adeno ca. The mean of primary tumor SUV max was measured as 14,09 ± 6,36 in all patients. The mean primary tumor SUVmax of the patients diagnosed with sTuamous ca was 14,51 ± 6,63, and the mean of primary tumor SUV max of the patients diagnosed with adeno ca was found to be 13,40 ± 6,03. Progression was observed in 7 of 9 patients whose treatment and follow-ups were continued in our hospital, and regression was observed in 2 of them. Conclusion: In the initial staging of patients diagnosed with esophageal ca, 18F-FDG PET/CT is an increasingly useful imaging method. Our study supports this.

Özet

Amaç: Özofagus kanseri(ca) tanısı alan ve 18F-Florodeoksiglukoz (18F-FDG) Pozitron Emisyon Tomografi / Bilgisayarlı Tomografi (PET/BT) görüntüleme kullanılarak evrelemesi yapılan hastaların bulgularını retrospektif olarak analiz etmeyi ve sunmayı amaçladık. Hastalar ve Yöntem: Bu çalışmaya Şubat 2015 ile Şubat 2020 tarihleri arasında hastanemizde 18F-FDG PET/ BT ile evrelemesi yapılmış 37 özofagus ca tanılı hasta dahil edildi. Hastaların yaş, cinsiyet, primer tümörün lokalizasyonu ve 18F-FDG PET/BT maksimum standardize alım değeri (SUVmax), mediastinal, abdominal ve servikal lenf nodları, akciğer(AC), karaciğer(KC), kemik ve diğer alanlara olan metastazlarına ait bulgular retrospektif olarak değerlendirildi. Bulgular: Hastaların yaş ortalaması 66,97± 4,54 yıl bulundu. 20 hasta (%54) erkek, 17 hasta (%46) kadındı. 10 hasta (%27) özofagus üst bölge tümörü, 23 hasta (%62) özofagus alt bölge tümörü, 4 hasta özofagus orta bölge tümörüydü (%11). 23 hastanın patolojik tanısı sTuamöz hücreli ca, 14 hastanın adeno ca olarak tespit edildi. Tüm hastalarda primer tümör SUVmax ortalaması 14,09±6,36 olarak ölçüldü. STuamöz ca tanılı hastaların primer tümör SUVmax ortalaması 14,51±6,63, adeno ca tanılı hastaların primer tümör SUVmax ortalaması 13,40±6,03 olarak bulundu. 8 hastada hiçbir metastaz bulgusuna rastlanmazken 29 hastada metastaz belirlendi. Ayrıca 3 hastada ise ikinci bir primer malignite (ikisi kolon ca, birisi nazofarenks ca) saptandı. Tedavi ve takiplerine hastanemizde devam edilen 9 hastanın 7’sinde progresyon, 2’sinde ise regresyon izlendi. Sonuç: Özofagus ca tanısı alan hastaların ilk evrelemesinde, 18F-FDG PET/BT günümüzde kullanım sıklığı gittikçe artan faydalı bir görüntüleme yöntemidir. Bizim çalışmamızda bunu destekler niteliktedir.

🔖

Cite This Article

APİLİOĞULLARI, B., KAYA, B. (2021). 18F-FDG PET/CT Findings in Esophageal Ca Staging: A Retrospective Analysis. Selçuk Tıp Dergisi, Cilt: 37 - Sayı: 4, 345–350. https://ajindex.com/articles/405010

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kılınç HE. Sağlıklı bireylerde farklı tip egzersiz eğitimlerinin suprahyoid kas aktivasyonu, disfaji limiti ve dil basıncı kuvvetine etkilerinin karşılaştırılması. Doktora tezi, Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü, Ankara, 2019
  2. Bulur O, Bas Y, Abdi OA. et al. The only and frst analysis of upper gastrointestinal endoscopy results from MogadishuSomalia. Turk Klin J Cardiovasc Sci 2018;30(1):1-5
  3. Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician 2017;95(1):22-8
  4. Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210-5
  5. Alıcı S, İzmirli M, Doğan E. Epidemiologic evaluation of the patients admitted to department of medical oncology, Yüzüncü Yıl University, Medical Faculty. Turk J Onc 2006;21(2):87-97 6. Betancourt Cuellar SL, Palacio DP, Benveniste MF, et al. Positron emission tomography/computed tomography in esophageal carcinoma: Applications and limitations. Semin Ultrasound CT MR 2017;38(6):571-83
  6. Özçelik MF. Özofagus kanseri: Tanı ve cerrahi tedavi. Gastrointestinal Sistem Hastalıkları Sempozyumu. İstanbul, 2001;241-51
  7. Türkyılmaz A. Diagnostic techniTues in esophageal cancer J Exp Clin med 2012;29:S.209-14
  8. Ökten I. Özofagus kanserleri: Ökten I, Güngör A. Gögüs cerrahisi cilt-II. Ankara: Tgcd 2003;1247-308
  9. Drudi FM,Trippa F, Cassone F, et al. Esophagogram and CT vs endoscopic and surgical specimens in the diagnosis of esophageal carcinoma. Radiol Med 2002;103:344-52
  10. Gore RM, Yaghmai Y, Ghahremani GG, Radiologic evaluation of the esophagus. In: Shields TW, Lo Cicero J, Ponn RB, Rusch VW, eds. General Thoracic Surgery, vol 2, 6th ed. Philadelphia: Lippincott Williams and Wilkins 2005;1939-55
  11. Turkyilmaz A, Eroglu A, Aydin Y. et al.The relationship of serum CEA and CA 19–9 levels to liver metastasis and pancreatic invasion in esophageal cancer. Turk J Med Sci 2009;39:895-9
  12. Turkyilmaz A, Eroglu A, Aydin Y, et al. Survival in esophageal cancer patients with hematogenous distant organ metastases. Turk J Med Sci 2009;39:415-21
  13. Wu LF, Wang BZ, Feng JL. et al. Preoperative TN staging of esophageal cancer. Comparison of mini probe ultrasonography, spiral CT and MRI. World J Gastroentero 2003;9:219-24
  14. Riedel M, Stein HJ, Mounyam L, et al. Predictors of tracheobronchial invasion of suprabifurcal oesophageal cancer. Respiration 2000;67:630-7
  15. Giovagnoni A, Valeri G, Ferrara C. MRI of esophageal cancer. Abdom Imaging 2002: